mRNA |
ML258 |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.07 |
mRNA |
Camptothecin |
GDSC1000 |
pan-cancer |
AAC |
-0.063 |
0.07 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.07 |
mRNA |
PF-573228 |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.07 |
mRNA |
regorafenib |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.07 |
mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.07 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.07 |
mRNA |
AP-24534 |
GDSC1000 |
pan-cancer |
AAC |
-0.062 |
0.07 |
mRNA |
TG-101348 |
GDSC1000 |
pan-cancer |
AAC |
-0.052 |
0.08 |
mRNA |
Bortezomib |
gCSI |
pan-cancer |
AAC |
0.1 |
0.08 |